Diurnal Group PLC Director Dealings (6269O)

TIDMDNL

RNS Number : 6269O

Diurnal Group PLC

18 May 2018

18 May 2018

Diurnal Group plc

("Diurnal" or the "Company")

Director Dealings

Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces that it has been notified of the following transaction in the Company's ordinary shares undertaken by Alan Raymond, Non-Executive Director, as a result of a re-registration to a nominee account. There has been no change of beneficial ownership as a result of this transfer of legal title.

 
 For further information, please visit www.diurnal.co.uk 
  or contact: 
 
                                            [phone] 
 Diurnal Group plc                           1000 
 Martin Whitaker, Chief Executive 
  Officer 
 Richard Bungay, Chief Financial 
  Officer 
 
 Panmure Gordon (UK) Limited (Nominated     [phone] 
  Adviser and Joint Broker)                  2500 
 Corporate Finance: Freddy Crossley, 
  Emma Earl 
 Corporate Broking: James Stearns 
 
 Cantor Fitzgerald Europe (Joint            [phone] 
  Broker)                                    7000 
 Corporate Finance: Phil Davies, 
  Will Goode, Michael Boot 
  Healthcare Equity Sales: Andrew 
  Keith 
 
                                            [phone] 
 FTI Consulting                              1000 
 Simon Conway 
 Victoria Foster Mitchell 
 

Notes to Editors

About Diurnal Group plc

Founded in 2004, Diurnal is a UK-based specialty pharma company developing high quality products for the global market for the life-long treatment of chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.

For further information about Diurnal, please visit www.diurnal.co.uk

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1     Details of the person discharging managerial 
        responsibilities / person closely associated 
----  -------------------------------------------------------------------- 
 a)    Name                             Alan Raymond 
----  ------------------------------  ------------------------------------ 
 2     Reason for the notification 
----  -------------------------------------------------------------------- 
 a)    Position/status                 Non-executive Director 
----  ------------------------------  ------------------------------------ 
 b)    Initial notification            Initial notification 
        /Amendment 
----  ------------------------------  ------------------------------------ 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  -------------------------------------------------------------------- 
 a)    Name                            Diurnal Group plc 
----  ------------------------------  ------------------------------------ 
 b)    LEI                             213800I2HNUNZN1LDH29 
----  ------------------------------  ------------------------------------ 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  -------------------------------------------------------------------- 
 a)    Description of                  Ordinary shares of 5 pence 
        the financial                   each in Diurnal Group plc 
        instrument, type 
        of instrument 
---- 
 
       Identification                  GB00BDB6Q760 
        code 
 
 b)    Nature of the                   Re-registration of ordinary 
        transaction                     shares with Redmayne Bentley 
                                        Stockbrokers 
----  ------------------------------  ------------------------------------ 
 c)    Price(s) and volume(s) 
----                                   ----------------  --------------- 
                                        Price(s)          Volume(s) 
----                                   ----------------  --------------- 
    Nil                                                   19,888 
   ----------------------------------------------------  --------------- 
 
 d)    Aggregated information          n/a 
---- 
 
 
 
 
 
 e)    Date of the transaction         14 May 2018 
----  ------------------------------  ------------------------------------ 
 f)    Place of the transaction        Outside a trading venue 
----  ------------------------------  ------------------------------------ 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFVSELITLIT

(END) Dow Jones Newswires

May 18, 2018 10:33 ET (14:33 GMT)